
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
(Reuters) – About one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight loss and related conditions, a poll by Kaiser Family Foundation (KFF) showed on Friday. The data also showed that 6% of those polled said they were currently using a GLP-1 drug, such as Novo Nordisk’s…